Skip to main content

Advertisement

SpringerLink
Log in

Caphosol, a therapeutic option in case of cancer therapy-induced oral mucositis in children?

Results from a prospective multicenter double blind randomized controlled trial

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Cheng KKF, Lee V, Li CH et al (2011) Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncol 47:153–162

    Article  PubMed  Google Scholar 

  2. Otmani N, Alami F, Hessissen L et al (2011) Determinants of severe oral mucositis in paediatric cancer patients: a prospective study. Int J Paediatr Dent 21(3):210–216

    Article  PubMed  Google Scholar 

  3. Allen G, Logan R, Gue S (2010) Oral manifestations of cancer treatment in children: a review of the literature. Clin J Oncol Nurs 14(4):481–490

    Article  PubMed  Google Scholar 

  4. Sonis ST, Elting LS, Keefe D et al (2004) Perspectives on cancer therapy-induced mucosal injury. pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995–2025

    Article  PubMed  Google Scholar 

  5. Singh M, Papas A (2009) Long-term clinical observation of dental caries in salivary hypofunction patients using a supersaturated calcium-phosphate remineralizing rinse. J Clin Dent 20(3):87–92

    PubMed  Google Scholar 

  6. Papas AS, Clark RE, Martuscelli G et al (2003) A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 31(8):705–712

    Article  PubMed  CAS  Google Scholar 

  7. Cancer Therapy Evaluation Program (2006) Common terminology criteria for adverse events, version 3.0. Aug 9, 2006. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed 19 May 2012

  8. Wong DL, Baker CM (1988) Pain in children: comparison of assessment scales. Pediatr Nurs 14(1):9–17

    PubMed  CAS  Google Scholar 

  9. Clarkson JE, Worthington HV, Furness S et al (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev Issue 8. doi:10.1002/14651858.CD001973.pub4

  10. Worthington HV, Clarkson JE, Bryan G et al (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Review, Issue 4. doi:10.1002/14651858.CD000978.pub5

  11. Waśko-Grabowska A, Rzepecki P, Oborska S et al (2011) Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience. Transplant Proc 43(8):3111–3113

    Article  PubMed  Google Scholar 

  12. Hawcutt D, Awoghemi O, Bell E et al (2010) Mucositis prevention: efficacy of supersaturated calcium and phosphate solution in high risk paediatric oncology patients. Pediatr Blood Cancer 55(5):PR025

    Google Scholar 

  13. Miyamoto C, Wobb J, Micaily B et al (2009) A retrospective match controlled study of supersaturated calcium phosphate oral rinse (Scpor) vs. supportive care for radiation induced oral mucositis (Om). [Abstract] (no. 10–087). Presented at the 2009 international MASCC/ISOO symposium; June 25–27, 2009; Rome, Italy. In: Support Care Cancer 17:911

  14. Bechtel T, Devine S, James AG (2009) Use of a calcium/phosphate oral rinse (Caphosol) to lessen the mucositis following an autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 15(2 Suppl):154

    Article  Google Scholar 

  15. Haas ML, Mercedes T, Manyak J et al (2008) Reduction of painful oral mucositis by supersaturated calcium phosphate oral rinse in head and neck cancer patients receiving chemotherapy and radiation. [Poster] (no. 2530). Presented at the 50th congress of the American Society of Therapeutic Radiology and Oncology 2008 (ASTRO); Sep 21–25, 2008; Boston, USA. http://astro2008.abstractsnet.com/acover.wcs?entryid=500686. Accessed 8 Feb 2012

  16. Mourao E, Correira A, Pires R (2010) Finally something good. [Abstract]. Presented at the 36th annual meeting of the European Group for Blood and Marrow Transplantation (EBMT); Mar 21–24, 2010; Vienna, Austria. In: Bone Marrow Transplantation (Suppl. 2) 45:S369

  17. Nicolatou-Galitis O, Sarri T, Kouloulias V et al (2010) Efficacy and safety of Caphosol on oral mucositis in head and neck cancer patients who received radiotherapy with or without chemotherapy. A pilot study. [Abstract] (no. 08–070). Presented at the 2010 international MASCC/ISOO symposium; June 24–26, 2010; Vancouver, Canada. In: Support Care Cancer 18:S111–S112

  18. Skorobogatova EV, Dyshlevaia ZM, Karachunsky AI et al (2011) First Russian experience of calcium phosphate mouth rinse usage for treatment of children with oral mucositis undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 46(Suppl 1):S192–S193

    Google Scholar 

  19. Lazic J, Janic D, Dokmanovic L et al (2011) Incidence of oral mucositis and efficient therapy with supersaturated calcium and phosphate solution in pediatric cancer patients. [Poster]. Presented at the 43rd congress of the International Society of Paediatric Oncology; Oct 26–30, 2011; Auckland, New Zealand. In: Ped Blood Canc 57(5):835

Download references

Acknowledgment

Study medications were sponsored by EUSA Pharma (international division of Jazz Pharmaceuticals).

Conflict of interest

The authors have declared no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Pediatric Hematology and Oncology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA, Utrecht, The Netherlands

    M. F. Raphael & A. M. den Boer

  2. Department of Pediatric Hematology and Oncology, Leiden University Medical Center, Leiden, The Netherlands

    W. J. W. Kollen & H. Mekelenkamp

  3. Department of Pediatric Hematology and Oncology, VU University Medical Center, Amsterdam, The Netherlands

    F. C. H. Abbink & G. J. L. Kaspers

  4. Department of Pediatrics, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands

    K. Zomer-Kooijker

  5. Department of Hospital and Clinical Pharmacy, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    B. H. W. Molmans

  6. Department of Pediatric Hematology and Oncology, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    W. J. E. Tissing

Authors
  1. M. F. Raphael
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. M. den Boer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. J. W. Kollen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Mekelenkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. C. H. Abbink
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. J. L. Kaspers
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Zomer-Kooijker
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. H. W. Molmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W. J. E. Tissing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. F. Raphael.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raphael, M.F., den Boer, A.M., Kollen, W.J.W. et al. Caphosol, a therapeutic option in case of cancer therapy-induced oral mucositis in children?. Support Care Cancer 22, 3–6 (2014). https://doi.org/10.1007/s00520-013-2015-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-013-2015-0

Keywords

Search

Navigation